| CRGY price | $11.43 at the August 3, 2026, 4:00 PM EDT market close, down 0.04 or 0.35% from the $11.47 July 31 close, after opening at $11.00 and trading in a session range of $11.00 to $11.45, with an after-hours quote of $11.93 up 0.50 or 4.37% | StockAnalysis.com real-time quote | August 4, 2026 |
| Market capitalization | Near $3.77 billion at the August 3, 2026 close, verified as the $11.43 price times 330.35 million shares, with the Q2 2026 Form 10-Q cover listing approximately 330,403,696 Class A shares outstanding as of July 31, 2026 | StockAnalysis.com quote and Crescent Q2 2026 Form 10-Q | August 4, 2026 |
| Q2 2026 production | 335 MBoe/d including 140 MBo/d of oil, about 42% oil and 64% liquids, with 43 gross operated wells drilled and 32 brought online during the quarter | Crescent Q2 2026 earnings release and Q2 2026 Form 10-Q | August 4, 2026 |
| Q2 2026 revenue | $1,394.95 million in total revenues, up from $897.98 million in Q2 2025, including $1,226.83 million of oil revenue and $129.37 million of NGL revenue | Crescent Q2 2026 earnings release | August 4, 2026 |
| Q2 2026 net income and EPS | GAAP net income of $493.7 million, net income attributable to Crescent of $492.8 million, adjusted net income of $263 million, and diluted EPS of $1.30, with GAAP results including a $181.9 million gain on derivatives | Crescent Q2 2026 earnings release and Q2 2026 Form 10-Q | August 4, 2026 |
| Q2 2026 cash flow | Record operating cash flow of $707 million, record levered free cash flow of $418 million, record adjusted EBITDAX of $798 million, and capital expenditures excluding acquisitions of $284 million | Crescent Q2 2026 earnings release | August 4, 2026 |
| Six-month 2026 cash flow | Net cash provided by operating activities of $1,115.98 million for the first six months of 2026, with $651.33 million of development capital spending and $354.42 million of acquisitions | Crescent Q2 2026 Form 10-Q cash flow statement | August 4, 2026 |
| TTM revenue | Approximately $4.31 billion over the trailing twelve months ended June 30, 2026, cross-checked between StockAnalysis.com financials at $4,309 million and the sum of quarterly revenue from the Q2 2026 Form 10-Q | StockAnalysis.com financials and Crescent Q2 2026 Form 10-Q | August 4, 2026 |
| Shares outstanding | 330.25 million shares per StockAnalysis.com, with 330,345,624 shares outstanding as of June 30, 2026 and approximately 330,403,696 as of July 31, 2026 per the Q2 2026 Form 10-Q | StockAnalysis.com statistics and Crescent Q2 2026 Form 10-Q | August 4, 2026 |
| Cash and debt | Cash and cash equivalents of $264.9 million, long-term debt of $5,166.02 million, and total debt of about $5.17 billion as of June 30, 2026, with a net debt near $4.9 billion | Crescent Q2 2026 Form 10-Q balance sheet | August 4, 2026 |
| Balance sheet totals | Total assets of $12,008.4 million, total liabilities of $6,848.8 million, and total equity of $5,159.6 million as of June 30, 2026 | Crescent Q2 2026 Form 10-Q balance sheet | August 4, 2026 |
| Vital Energy merger | Closed in December 2025, with Crescent issuing 73.3 million shares of Class A common stock and paying $3.7 million in cash, adding Permian assets, and the share count rising 78.45% year over year as a result of the merger and related transactions | Crescent Q2 2026 Form 10-Q acquisition note | August 4, 2026 |
| 2026 guidance | Total production of 327 to 335 MBoe/d raised from 320 to 335, oil production of 40% to 42%, adjusted opex of $11.00 to $12.00 per Boe lowered from $11.50 to $12.50, production taxes of 5.0% to 6.0%, and development capital of $1,325 to $1,425 million unchanged | Crescent Q2 2026 earnings release guidance update | August 4, 2026 |
| Permian synergy target | Raised to approximately $250 million to $300 million, roughly three times the original target, with about $190 million captured to date | Crescent Q2 2026 earnings release | August 4, 2026 |
| Liquidity and debt maturity | Approximately $2.2 billion of liquidity as of June 30, 2026, with about $2.0 billion expected after the July 2026 redemption of the remaining $259 million of 7.75% senior notes due 2029 at par, eliminating the nearest maturity | Crescent Q2 2026 earnings release | August 4, 2026 |
| Dividend and buyback | Quarterly dividend of $0.12 per share, or $0.48 per share annualized, approved August 3, 2026 and payable August 31, 2026, representing a 4.20% yield at the $11.43 close, with approximately $336 million of share repurchase authorization remaining | Crescent Q2 2026 Form 10-Q and StockAnalysis.com dividend data | August 4, 2026 |
| Hedging position | Economically hedged production of 66% of oil and 52% of natural gas in Q2 2026, with realized oil prices of $96.61 per barrel before derivatives and $73.33 after derivatives | Crescent Q2 2026 Form 10-Q derivative disclosure | August 4, 2026 |
| Valuation check | Forward P/E near 4.78, price-to-sales near 0.99, price-to-book near 0.81, price-to-free-cash-flow near 10.09, and EV/EBITDA near 4.12 at the $11.43 close | StockAnalysis.com statistics | August 4, 2026 |
| Analyst consensus | Buy rating across 15 analysts with an average price target of $15.93, low of $11, median of $16, and high of $19, implying about 39% upside from the $11.43 close | StockAnalysis.com forecast and analyst ratings | August 4, 2026 |
| Analyst rating mix, August 2026 | 10 Strong Buy, 2 Buy, and 3 Hold out of 15 analysts, with recent actions including Evercore ISI Buy at $18 on July 27, Wells Fargo Buy at $18 on July 24, BMO Hold at $13 on July 23, Siebert Williams Shank Buy at $16 on July 21, and UBS initiation at Buy with a $13 target in July | StockAnalysis.com forecast recommendation trends | August 4, 2026 |
| 2026 and 2027 consensus estimates | Fiscal 2026 revenue estimate of about $4.78 billion with adjusted EPS of $2.28, and fiscal 2027 revenue estimate of about $4.60 billion with adjusted EPS of $2.26, with 2026 adjusted EPS estimates ranging from $1.74 to $2.81 | StockAnalysis.com forecast financial forecast | August 4, 2026 |
| Short interest | 41.74 million shares short, or 12.64% of shares outstanding and 14.13% of float, up from 37.11 million the prior month, with 6.47 days to cover | StockAnalysis.com statistics short selling | August 4, 2026 |
| 52-week range and performance | 52-week range of $7.68 to $14.29, up 27.57% over the trailing 52 weeks, with a beta near 0.89 | StockAnalysis.com quote and statistics | August 4, 2026 |
| Technical snapshot | 50-day moving average near $10.90 and 200-day moving average near $10.55 on StockAnalysis.com statistics, 14-day RSI near 59.87, and 20-day average volume near 5.69 million shares as of August 3, 2026 | StockAnalysis.com statistics | August 4, 2026 |
| Credit and efficiency scores | Altman Z-score of 0.42 and Piotroski F-score of 4 on StockAnalysis.com, with debt-to-EBITDA near 2.40, interest coverage near 2.69, and a current ratio near 0.57 as of August 3, 2026 | StockAnalysis.com statistics | August 4, 2026 |